xGen® Acute Myeloid Leukemia Cancer Panel
The xGen AML Cancer Panel v1.0 comprises 11,743 xGen Lockdown® Probes, spanning 1.19 Mb of the human genome, for targeted enrichment of >260 genes associated with AML, to provide more efficient detection of disease-causing mutations.
- Obtain high coverage uniformity with 98% of genomic targets covered at greater than 0.2 x mean coverage
- Detect variations reliably with high reproducibility and increased depth of coverage
- Observe high relevance for AML-related applications due to empirically derived targets
- Enjoy fast turnaround via easy online ordering and next day shipping